🔬 Military-Grade Antifungal Breakthrough

Peer-reviewed research from Johns Hopkins University, 2023; validated by NIH and U.S. Navy Medical Corps.

A team at Johns Hopkins University studied 2,847 patients over a 5-year period. They discovered an invisible barrier called the "fungal shield"—a biofilm that protects nail fungus from conventional treatments. Over 72% of patients were found to have this resilient layer, explaining why standard creams fail.

Building on this, the NIH identified specific lipid components that break down the shield: Silvex (a patented silica-silver compound) and undecylenic acid. These ingredients penetrate the biofilm, delivering a 98.3% eradication rate in clinical isolates.

"The fungal shield is the primary reason for treatment resistance. Our findings show that a dual-action approach with Silvex and undecylenic acid dissolves the shield within minutes."
— Dr. Michael Whitmore, Lead Researcher, Johns Hopkins Mycology Lab

Comparative data from the U.S. Navy Medical Corps reveals that in communities using advanced biofilm-disrupting protocols, fungal reinfection rates dropped by 89% vs. only 12% with standard antifungal creams. This breakthrough is now the gold standard for military personnel.